Mayhew Philipp D, Boston Sarah E, Zwingenberger Allison L, Giuffrida Michelle A, Runge Jeffrey J, Holt David E, Raleigh Joseph S, Singh Ameet, Culp William T N, Case J Brad, Steffey Michele A, Balsa Ingrid M
School of Veterinary Medicine, University of California-Davis, Davis, California.
VCA Canada, 404 Veterinary Emergency and Referral Hospital, Newmarket, Ontario, Canada.
Vet Surg. 2019 Jul;48(5):742-750. doi: 10.1111/vsu.13221. Epub 2019 Apr 29.
To report the morbidity and mortality associated with adrenalectomy with cavotomy for resection of invasive adrenal neoplasms in dogs and evaluate risk factors for perioperative outcomes.
Retrospective study.
Forty-five client-owned dogs.
Dogs that underwent open adrenalectomy with cavotomy for resection of adrenal masses with tumor thrombus extending into the vena cava were included. Clinicopathologic data were harvested from medical records. Selected clinical, imaging, and operative variables were statistically evaluated as risk factors for packed red blood cell transfusion, nephrectomy, perioperative death, and overall survival.
Thirty-six of 45 masses were pheochromocytomas, 7 were adrenocortical carcinomas, and 2 were unknown type. Caval thrombus terminated prehepatically in 21 of 45 dogs and extended beyond the porta hepatis but terminated prediaphragmatically (intrahepatic prediaphragmatic location) in 15 dogs and thrombi extended postdiaphragmatically in 5 dogs. Thirty-four (76%) dogs were discharged from the hospital, and 11 (24%) dogs died or were euthanized prior to discharge. Median overall survival time for all 45 dogs was 547 days (95%CI 146-710). Bodyweight, tumor type, and size and extent of caval thrombus did not affect survival to discharge, but postdiaphragmatic (rather than prediaphragmatic) thrombus termination was associated with a greater risk of death.
Long-term survival was common in dogs that survived the perioperative period. Postdiaphragmatic thrombus extension affected the prognosis for overall survival.
Findings of this study help to stratify operative risk in dogs with adrenal neoplasia and caval invasion.
报告犬侵袭性肾上腺肿瘤切除术中肾上腺切除术加腔静脉切开术的发病率和死亡率,并评估围手术期结果的危险因素。
回顾性研究。
45只客户拥有的犬。
纳入因切除肾上腺肿块并伴有肿瘤血栓延伸至腔静脉而接受开放性肾上腺切除术加腔静脉切开术的犬。从病历中收集临床病理数据。对选定的临床、影像学和手术变量进行统计学评估,作为红细胞输血、肾切除术、围手术期死亡和总生存期的危险因素。
45个肿块中36个为嗜铬细胞瘤,7个为肾上腺皮质癌,2个类型不明。45只犬中有21只的腔静脉血栓在肝门前终止,15只延伸至肝门以外但在膈前(肝内膈前位置)终止,5只血栓延伸至膈后。34只(76%)犬出院,11只(24%)犬在出院前死亡或实施安乐死。所有45只犬的中位总生存期为547天(95%CI 146 - 710)。体重、肿瘤类型以及腔静脉血栓的大小和范围不影响出院存活率,但膈后(而非膈前)血栓终止与更高的死亡风险相关。
围手术期存活的犬长期存活较为常见。膈后血栓延伸影响总生存期预后。
本研究结果有助于对患有肾上腺肿瘤和腔静脉侵犯的犬的手术风险进行分层。